Salesforce Friends ...
Health Care: Drugs
Dendreon Corp (DNDN: NASDAQ)
$5.91 -0.85 | -12.57%
06/04/12 - 04:00 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 6.76 |
| 52 Week High | 42.00 |
| 52 Week Low | 6.46 |
| Avg. Daily Vol. (Mil) | 6.69 |
| Beta (3 year) | 2.66 |
| Share Related Items | |
| Mkt Cap (Mil) | 1,041.00 |
| Shares Out (Mil) | 153.99 |
| Float (Mil) | 150.61 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 6.20 |
| Current Ratio | 7.30 |
| LT Debt/ Equity | 2.04 |
| Total Debt / Equity | 2.05 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 2.62 |
| Price/Book | 3.72 |
| Price/Cash Flow | -4.00 |
| Per Share Data | |
| Earnings | -2.22 |
| Sales | 2.58 |
| Book Value | 1.82 |
| Cash Flow | -1.69 |
| Business Summary | |
|---|---|
| Dendreon Corporation is a biotechnology company focused on the discovery, development and commercialization of novel therapeutics that improve cancer treatment options for patients. | |
| General Information | |
| 3005 First Avenue
Seattle, WA 98121 |
|
| www.dendreon.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 1475 | |
| CEO: John H. Johnson | |
| Short Interest | |
| Current Month (Mil) | 33.23 |
| Previous Month (Mil) | 32.95 |
| Short Interest Ratio (Days) | 4.90 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -34.80 |
| Return on Investments | -38.00 |
| Profitability | |
| Gross Margin | 66.50 |
| EBIT Margin | -69.10 |
| Profit Margin | -82.30 |
Portfolios with DNDN
- Portfolio NameUser Type
- UserLong Term Stock Picks
- UserTop 10 Small Cap Stock Picks
- ContributorBreakout Stocks Of The Week...
- UserS ACCT
- UserRISK
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- ContributorRelative Strength Trades fo...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
Latest DNDN Headlines from TheStreet
- Dendreon Stock Hits New 52-Week Low (DNDN) 06.04.12 | 10:06 am
- ASCO 2012 Live Blog -- Monday 06.04.12 | 06:06 am
- ASCO '12 Stocks: Winners and Losers 06.04.12 | 06:06 am
- ASCO 2012 Live Blog -- Saturday 06.02.12 | 07:06 am
- J&J Scores Big With Prostate Cancer Pill 06.02.12 | 12:06 am
- Biotech Stock Mailbag: ASCO, Celldex, Obesity Drug Game-Changer 05.25.12 | 05:05 am
- The Next Big Thing in Biotech: ASCO Conference
05.25.12 | 05:05 am - Dendreon Management Presents At Bank Of America Merrill Lynch 2012 Health Care Conference (Transcript) 05.17.12 | 01:05 am
- Dendreon Management Presents At Deutsche Bank Securities, Inc. 37th Annual Health Care Conference (Transcript) 05.11.12 | 07:05 pm
- Dendreon Stock Gaps Down On Today's Open (DNDN) 05.08.12 | 08:05 am
Press Releases for DNDN
- Dendreon Announces Webcast Presentations At Upcoming Conferences - Business Wire 05.25.12 | 08:05 pm
- Dendreon Announces Data Presentation At The 2012 American Urological Association Annual Meeting - Business Wire 05.21.12 | 10:05 am
- Dendreon Announces Presentation Of PROVENGE Data At The 2012 American Society Of Clinical Oncology Annual Meeting - Business Wire 05.16.12 | 06:05 pm
- Dendreon Reports Net PROVENGE Product Revenues Of $82 Million, Achieved 6.5% Quarter-Over-Quarter Growth - Business Wire 05.07.12 | 04:05 pm
- Jennerex Elects Dr. Mitchell H. Gold To Board Of Directors - PR Newswire 04.17.12 | 07:04 am
- Dendreon To Host Conference Call On May 7 To Announce First Quarter Financial Results And Webcast Presentations At Upcoming Conferences - Business Wire 04.09.12 | 05:04 pm
- Genesis Biopharma Names Biotech Industry Veteran Hans E. Bishop As Executive Chairman Of The Board - PR Newswire 03.22.12 | 08:03 am
- Dendreon Announces Webcast Presentation At Upcoming Conferences - Business Wire 03.05.12 | 08:03 am
- Dendreon Announces Executive Appointments - Business Wire 02.28.12 | 05:02 pm
- Dendreon Reports Fourth Quarter And 2011 Year End Financial Results - Business Wire 02.27.12 | 08:02 am
Partner Headlines for DNDN
- Analyst Alerts: General Motors, Valero, Copa Holdings, Dendreon June 4th - Wall St. Cheat Sheet 06.04.12 | 10:06 am
- Active Stock Alerts: Dendreon, Delcath Systems, Johnson & Johnson, Boeing, Onyx June 4th - Wall St. Cheat Sheet 06.04.12 | 10:06 am
- Stock Insights: Dendreon, Medtronic, FedEx, ArQule, Rentrak June 4th - Wall St. Cheat Sheet 06.04.12 | 10:06 am
- Social Media Outlook for Monday June 4 (AUXL, NFLX, DNDN, IBM) - Benzinga 06.04.12 | 09:06 am
- Healthcare Business Recap: Dendreon BOMBS, Cancer Cures Galore - Wall St. Cheat Sheet 06.04.12 | 06:06 am
- J&J and 2 Dow 30 Stocks BUZZING Now - Wall St. Cheat Sheet 06.04.12 | 04:06 am
- 3 BOMBS Getting Dropped on Dendreon Now - Wall St. Cheat Sheet 06.04.12 | 03:06 am
- Baxter And Neostem Validating Each Other's Cell Therapies - Seeking Alpha 06.01.12 | 09:06 am
- IsoRay: A Potential Small-Cap Bio-Pharma Multi-Bagger - Seeking Alpha 05.29.12 | 09:05 am
- Analyst Alerts: VeriFone, Dendreon, TD Bank May 25th - Wall St. Cheat Sheet 05.25.12 | 11:05 am
